Company Overview of Ardelyx, Inc.
Key Executives for Ardelyx, Inc.
|Michael G. Raab||28 Relationships||Chief Executive Officer, President and Director||51|
|Mark E. Kaufmann MBA||5 Relationships||Chief Financial Officer and Principal Accounting Officer||48|
|Jeremy S. Caldwell Ph.D.||5 Relationships||Chief Scientific Officer and Executive Vice President||47|
|Elizabeth A. Grammer Esq.||No Relationships||Senior Vice President and General Counsel||52|
|Paul Korner M.D., M.B.A.||No Relationships||Chief Medical Officer and Executive Vice President||50|
|View More Key Executives|
Ardelyx, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|David M. Mott NEA||188 Relationships||Mersana Therapeutics, Inc.||51|
|Michael G. Raab||28 Relationships||Ardelyx, Inc.||51|
|Richard J. Rodgers||24 Relationships||Ardelyx, Inc.||49|
|Gordon Ringold Ph.D.||26 Relationships||Alavita Pharmaceuticals Inc.||65|
|Annalisa Jenkins MBBS, MRCP||84 Relationships||Dimension Therapeutics, Inc.||51|
Ardelyx, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Audit Committee||Richard J. Rodgers||24 Relationships||3 Executives|
|Compensation Committee NEA||David M. Mott||188 Relationships||3 Executives|
|Nominating Committee Ph.D.||Gordon Ringold||26 Relationships||2 Executives|
|Corporate Governance Committee Ph.D.||Gordon Ringold||26 Relationships||2 Executives|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation||$470.0K|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.